Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as Wegovy) helped reduce cravings in people with alcohol use disorders. The drug also seemed to reduce the quantity… read on > read on >
Too often, ADHD and autism coincide in children. New research finds that for many of those kids, this dual diagnosis continues into adult life. Having attention deficit hyperactivity disorder (ADHD) alongside an autism diagnosis was also linked to worse health outcomes overall for adults, the study found. “Generally speaking, rates of ADHD decrease as children grow… read on > read on >
As closures of rural hospitals across the United States continue, more Americans are facing hour-plus drives to reach surgical centers, two new reports find. By 2020, data show, 99 million Americans already had trouble finding “timely, high-quality and affordable surgical care,” according to a news release from the University of Michigan. The situation is most… read on > read on >
The tragic early death of “Friends” star Matthew Perry from a ketamine overdose in 2023 has swung a spotlight on the dangers of unsupervised use of the potent anesthetic. Now, America’s leading group representing anesthesiologists is issuing new guidelines on proper use of the drug. Ketamine has also come under increasing scrutiny as a treatment… read on > read on >
Hardware and software changes, updates, and configurations can result in undelivered critical safety alerts read on >
High or very high outpatient respiratory illness activity reported in 43 states in last week of January read on >
A federal judge has temporarily blocked the National Institutes of Health (NIH) from making big cuts in medical research funding ordered by the Trump administration. The proposed cost-cutting could have reduced support for hospitals, universities and labs across the country. Monday’s ruling by U.S. District Judge Angel Kelley puts on hold funding caps for indirect… read on > read on >
Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new research shows. Compared to another common class of kidney medications, called DPP4is, GLP1-RA medications did better in helping slow the progression of kidney disease, keeping kidney disease patients out of the hospital and helping… read on > read on >
It was a bit safer to go into the water last year: Unprovoked shark attacks worldwide fell by about a third in 2024 compared to the year before, new data show. The United States continues to be the most likely country in which to get bitten by a shark, according to the annual International Shark… read on > read on >
Chronic ills like heart disease, asthma or diabetes afflict a majority of U.S. workers, but 60% of those affected say they’ve kept their health issue a secret from employers, a new poll finds. More than a third of workers battling chronic conditions also said they’d skipped a necessary medical appointment over the past year for… read on > read on >
